2 05, 2019 Paola Bordi et al., From the beginning to resistance: Study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC Diatech Pharmacogenetics2020-01-22T12:42:03+01:00 Read More
19 03, 2019 Paola Bordi et al., From the beginning to resistance: study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC Diatech Pharmacogenetics2020-01-22T12:44:53+01:00 Read More
